Skip to content
CorpDev.Org

CorpDev.Org

Daily News for Dealmakers

Monday 16th June 2025
  • Hire Me for M&A/PE Projects!
  • AI Assisted Due Diligence
  • Private Equity
  • Tech, Media & Telecom
  • Financial Services
  • Healthcare & Life Sciences
  • Consumer & Industrial
  • Energy & Utilities
CorpDev.Org

CorpDev.Org

Daily News for Dealmakers

  • Hire Me for M&A/PE Projects!
  • AI Assisted Due Diligence
  • Private Equity
  • Tech, Media & Telecom
  • Financial Services
  • Healthcare & Life Sciences
  • Consumer & Industrial
  • Energy & Utilities

Day: October 11, 2024

CyberArk’s $1.5B Venafi Buy Boosts Digital Identity Security

CyberArk’s $1.5B Venafi Buy Boosts Digital Identity Security

  • October 11, 2024
  • 0 Comments
  • By CorpDev
Strategic Acquisition: CyberArk's $1.5B acquisition of Venafi expands its identity security capabilities, integrating machine identity management to provide holistic solutions. Industry Shift: The...
Posted in Technology, Media and Telecom
7-Eleven Owner Defies $47B Buyout, Plans Corporate Split

7-Eleven Owner Defies $47B Buyout, Plans Corporate Split

  • October 11, 2024
  • 0 Comments
  • By CorpDev
Resisting Record Buyout: Seven & i Holdings Co., the parent company of 7-Eleven, is resisting a record $47 billion buyout proposal from Alimentation Couche-Tard, representing a 22% increase from the...
Posted in Big Deal, Consumer and Industrial, Deal Drama
Rio Tinto’s $6.7B Arcadium Buy: Lithium’s Soaring M&A Value

Rio Tinto’s $6.7B Arcadium Buy: Lithium’s Soaring M&A Value

  • October 11, 2024
  • 0 Comments
  • By CorpDev
Strategic Acquisition: Rio Tinto's $6.7 billion acquisition of Arcadium Lithium positions it as a major player in the lithium (lithium mining) sector, securing significant resource supply and...
Posted in Big Deal, Energy & Utilities, International
Pfizer’s Legal Threats: A Governance Crisis Unfolds

Pfizer’s Legal Threats: A Governance Crisis Unfolds

  • October 11, 2024
  • 0 Comments
  • By CorpDev
Corporate Governance Scrutiny: Pfizer's legal threats against former executives Ian Read and Frank D'Amelio for collaborating with activist investor Starboard Value have raised concerns about...
Posted in Big Deal, Deal Drama, Healthcare and Life Sciences
ArcelorMittal’s AM/NS Calvert Acquisition: Reshaping the Steel Industry Landscape

ArcelorMittal’s AM/NS Calvert Acquisition: Reshaping the Steel Industry Landscape

  • October 11, 2024
  • 0 Comments
  • By CorpDev
Strategic Acquisition: ArcelorMittal's acquisition of Nippon Steel's 50% stake in AM/NS Calvert for $1 strengthens its position in the North American steel market. Regulatory Compliance: The deal...
Posted in Consumer and Industrial, International
Private Equity Firms Face Soaring Defaults: Moody’s Analysis Reveals Higher Risks

Private Equity Firms Face Soaring Defaults: Moody’s Analysis Reveals Higher Risks

  • October 11, 2024
  • 0 Comments
  • By CorpDev
Alarming Default Rates: Private equity-backed firms faced a 17% default rate from Jan 2022 to Aug 2023, nearly double the 9% rate for non-PE firms. Top Sponsors Impacted: Major PE sponsors like...
Posted in Big Deal, Deal Drama, Private Equity
BlackRock Eyes $10B HPS Buyout: Private Credit Market Shakeup

BlackRock Eyes $10B HPS Buyout: Private Credit Market Shakeup

  • October 11, 2024
  • 0 Comments
  • By CorpDev
Strategic Acquisition Target: HPS Investment Partners, a leading $117 billion private credit firm, emerges as a prime $10+ billion acquisition target for BlackRock. Sector Growth: The private credit...
Posted in Big Deal, Private Equity
Citi Boosts West Coast M&A with Veteran Hire, John LaVoie

Citi Boosts West Coast M&A with Veteran Hire, John LaVoie

  • October 11, 2024
  • 0 Comments
  • By CorpDev
Strategic Hire: Citigroup bolsters its private equity M&A capabilities by hiring John LaVoie, a veteran investment banker with deep West Coast sponsor relationships. Sector Focus: LaVoie's expertise...
Posted in Private Equity
Sanofi’s $16B Consumer Health Unit Deal: A Strategic OTC Shift

Sanofi’s $16B Consumer Health Unit Deal: A Strategic OTC Shift

  • October 11, 2024
  • 0 Comments
  • By CorpDev
Strategic Shift: Sanofi's $16.4B deal to sell 50% stake in Opella consumer health unit to CD&R signals strategic focus on innovative medicines and vaccines. Industry Trend: Major pharma players like...
Posted in Healthcare and Life Sciences

CorpDev.Org

24×7 real time deals updates for everyone associated with deals.  Bookmark the page!

Daily M&A/PE News In 5 Min

Recent Posts

  • Bojangles Considers $1.5 Billion Sale Amid Surging Demand for Chicken Concepts
  • Pennsylvania House Votes to Scrutinize Private-Equity Healthcare Takeovers
  • BioNTech Consolidates mRNA Leadership with Strategic $1.25 Billion CureVac Acquisition
  • US-China Tech Decoupling Accelerates as Eight Roads Exits 40 Chinese Startups
  • Mitsubishi Estate’s Strategic Play: Acquiring Patron Capital to Dominate European Real Estate Debt Markets

Categories

  • Hire Me for M&A/PE Projects!
  • AI Assisted Due Diligence
  • Private Equity
  • Tech, Media & Telecom
  • Financial Services
  • Healthcare & Life Sciences
  • Consumer & Industrial
  • Energy & Utilities

Daily M&A/PE News In 5 Min

Deals by month

  • June 2025 (99)
  • May 2025 (163)
  • April 2025 (86)
  • January 2025 (53)
  • November 2024 (62)
  • October 2024 (102)
  • September 2024 (97)
  • August 2024 (165)
  • July 2024 (20)
  • March 2023 (7)
  • November 2022 (41)
  • October 2022 (89)
  • September 2022 (190)
  • August 2022 (80)
  • July 2022 (2)
  • June 2022 (79)
  • May 2022 (1)

Copyrights belong to 'Sources' referred to in each article, unless the articles are originally published by CorpDev.org in which case the copyright belongs to CorpDev.org